全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diabetic Polyneuropathy and Associated Factors in a Population of Type 2 Diabetic Patients in Garoua, Cameroon

DOI: 10.4236/jdm.2025.153010, PP. 131-142

Keywords: Type 2 Diabetes, Diabetic Polyneuropathy, Associated Factors, Cameroon

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Diabetic polyneuropathy (DPN) is the most common complication of diabetes, affecting nearly half of patients with type 2 diabetes. The aim of this study was to determine the prevalence and factors associated to DPN. Methods: We conducted a cross-sectional study from January to May 2024 at the Garoua Regional Hospital (GRH) and the Garoua General Hospital (HGG), involving type 2 diabetic patients. The DN-4 questionnaire, a screening tool for diabetic polyneuropathy comprising 10 items, was used as a diagnostic tool. The diagnosis was established based on a score ≥ 4. A logistic regression model was used to identify factors associated to DPN. The significance level was set at 5%. Results: Among the 203 patients included in the study, with a median (IQR) age of 56 (48 - 63) years, 68.5% were female. The median (IQR) duration of diabetes was 5 (2 - 9) years, with a median (IQR) glycated hemoglobin level of 8.80% (7.50% - 10.6%). Dyslipidemia was the most common additional cardiovascular risk factor (65.35%). The prevalence (95% CI) of painful diabetic neuropathy was 45.81% (38.82% - 52.96%). The main associated factors [aOR (95% CI), p] were female sex [3.65 (1.62 - 8.23), p = 0.037], age ≥ 60 years [4.57, (2.11 - 9.86), (p = 0.048)], diabetes duration ≥ 10 years [2.93. (1.16 - 7.45), (p = 0.006)], glycated hemoglobin level ≥ 7% [3.99, (1.25 - 5.72), (p = 0.043)] and chronic kidney disease [4.79, (2.22 - 7.54), (p = 0.009)]. Conclusion: The high prevalence of diabetic polyneuropathy and its multiple associated factors highlight a major challenge in its prevention, particularly through optimal glycaemic control, in order to improve patients’ quality of life.

References

[1]  Magliano, D.J., Boyko, E.J. and IDF Diabetes Atlas 10th Edition Scientific Committee (2021) IDF Diabetes Atlas. 10th Edition, International Diabetes Federation.
http://www.ncbi.nlm.nih.gov/books/NBK581934/
[2]  Glovaci, D., Fan, W. and Wong, N.D. (2019) Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Current Cardiology Reports, 21, 21.
https://doi.org/10.1007/s11886-019-1107-y
[3]  Lutte contre le diabète au Cameroun Riposte collective contre le tueur silencieux| MINSANTE.
https://www.minsante.cm/site/?q=fr/content/lutte-contre-le-diab%C3%A8te-au-cameroun-riposte-collective-contre-le-tueur-silencieux
[4]  Elleuch, M., Hssine, H., Affes, L., Salah, B., Boujelbene, K.H., Khlif, R., et al. (2023) Prévalence et facteurs prédictifs de la polyneuropathie distale et symétrique diabétique. JI MSfax, 44, 38-42.
https://www.medecinesfax.org/useruploads/files/Article6-44.pdf
[5]  Davies, M., Brophy, S., Williams, R. and Taylor, A. (2006) The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. Diabetes Care, 29, 1518-1522.
https://doi.org/10.2337/dc05-2228
[6]  Owolabi, L.F., Alghamdi, M., Adamu, B., Taura, M.G., Jibo, A., Almansour, M., et al. (2022) Magnitude of Diabetic Peripheral Neuropathy in Saudi Arabia: A Systematic Review and Meta-Analysis. BMC Endocrine Disorders, 22, Article No. 266.
https://doi.org/10.1186/s12902-022-01167-4
[7]  Dumont, I. (2011) Painful Diabetic Neuropathy: Diagnosis and Management. Diabetes & Metabolism.
https://www.academia.edu/22790870/Painful_diabetic_neuropathy_Diagnosis_and_management
[8]  Aynaou, H. and Latrech, H. (2019) Neuropathie Diabétique Périphérique Au CHU Mohamed VI d’Oujda. IOSR-JDMS, 18, 64-68.
https://www.iosrjournals.org/iosr-jdms/papers/Vol18-issue8/Series-5/M1808056468.pdf
[9]  Chahbi, Z., Lahmar, B., El Hadri, S., Abainou, L., Kaddouri, S., Qacif, H., et al. (2018) The Prevalence of Painful Diabetic Neuropathy in 300 Moroccan Diabetics. Pan African Medical Journal, 31, Article No. 158.
https://doi.org/10.11604/pamj.2018.31.158.14687
[10]  Simo, N., Kuate-Tegueu, C., Ngankou-Tchankeu, S., Doumbe, J., Maiga, Y., Cesari, M., et al. (2020) Correlates of Diabetic Polyneuropathy of the Elderly in Sub-Saharan Africa. PLOS ONE, 15, e0240602.
https://doi.org/10.1371/journal.pone.0240602
[11]  Dehayem Yefou, M., Sobngwi, E., Nwatsock, J.F., Maka Mani, J., Jupkwo, B. and Mbanya, J.C. (2010) P86 Prise en charge du diabète sucré au Cameroun: Résultats de l’étude Diabcare. Diabetes & Metabolism, 36, A59-A60.
https://doi.org/10.1016/s1262-3636(10)70234-2
[12]  Sonafouo, D.V., Kamguia, L., Endomba, T., Chetcha, B., Sobngwi, E., Mbanya, J.C., et al. (2018) Neuropathie diabétique et facteurs associés dans une population de patients diabétiques de type 1 au cameroun. Société francophone du diabète.
https://www.researchgate.net/publication/324784044_EP-132_Neuropathie_diabetique_et_facteurs_associes_dans_une_population_de_patients_diabetiques_de_type_1_au_Cameroun
[13]  Spallone, V., Morganti, R., D’Amato, C., Greco, C., Cacciotti, L. and Marfia, G.A. (2012) Validation of DN4 as a Screening Tool for Neuropathic Pain in Painful Diabetic Polyneuropathy. Diabetic Medicine, 29, 578-585.
https://doi.org/10.1111/j.1464-5491.2011.03500.x
[14]  Mojaddidi, M.A., Aboonq, M., Al Nozha, O.M., Allam, A. and Fath El-Bab, M. (2011) Early Diagnosis of Diabetic Neuropathy in Almadinah Almunawwarah. Journal of Taibah University Medical Sciences, 6, 121-131.
https://doi.org/10.1016/s1658-3612(11)70173-1
[15]  Hode, A.K., Dedjan, H. and Sondjo, F.M. (2023) Peripheral Neuropathy and Associated Factors in Diabetics at the CNHU-HKM of Cotonou in 2021. Journal of Diabetes Mellitus, 13, 12-22.
https://doi.org/10.4236/jdm.2023.131002
[16]  Halawa, M.R., Karawagh, A., Zeidan, A., Mahmoud, A.H., Sakr, M. and Hegazy, A. (2009) Prevalence of Painful Diabetic Peripheral Neuropathy among Patients Suffering from Diabetes Mellitus in Saudi Arabia. Current Medical Research and Opinion, 26, 337-343.
https://doi.org/10.1185/03007990903471940
[17]  Sani, M.A.M., Djibo, I.M. Andia, A., Madougou, S., Brah, S., Beydou, S.S., et al. (2015) Facteurs associés à la neuropathie diabétique à l’Hôpital National de Lamordé (Niamey-Niger). Health Sciences and Disease, 16, 546.
https://www.hsd-fmsb.org/index.php/hsd/article/view/546
[18]  Brown, M.J. and Asbury, A.K. (1984) Diabetic Neuropathy. Annals of Neurology, 15, 2-12.
https://doi.org/10.1002/ana.410150103
[19]  Bassanguen, P., Ewane, M.E., Doumbè, J. and Adiogo, D. (2019) Evaluation de la neuropathie par le vibrocheck chez le diabétique à l’hôpital général de Douala. Yaoundé Congres Hall. OERF035.
https://tropical-cardiology.com/Accueil/index.php/2013-08-10-06-44-55/n-special-151-jan-fev-mars-2018/304-p4-evaluation-de-la-neuropathie-par-le-vibrocheck-chez-le-diabetique-a-l-hopital-general-de-douala

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133